Registration is now open for the American Society for Dermatologic Surgery (ASDS)'s first hybrid annual meeting featuring two meeting experiences: in-person October 14-17 in Chicago, and virtually November 19-21.
Accepted abstracts and posters provide key updates on Xeomin (incobotulinumtoxinA) and Radiesse.
Galderma has received regulatory approval in the European Union, United States, and Canada for a new syringe designed for use with its NASHA lidocaine range of Restylane products.
